Comprehensive Ocular and Systemic Safety Evaluation of Polysialic Acid-Decorated Immune Modulating Therapeutic Nanoparticles (PolySia-NPs) to Support Entry into First-in-Human Clinical Trials.

Autor: Krishnan, Anitha1 (AUTHOR) akrishnan@avicedarx.com, Callanan, David G.1 (AUTHOR) dcallanan@avicedarx.com, Sendra, Victor G.1 (AUTHOR) alad@avicedarx.com, Lad, Amit1 (AUTHOR) schristian@avicedarx.com, Christian, Sunny1 (AUTHOR) rearla@avicedarx.com, Earla, Ravinder1 (AUTHOR) akhanehzar@avicedarx.com, Khanehzar, Ali1 (AUTHOR) mgreene@avicedarx.com, Tolentino, Andrew J.2 (AUTHOR) atolent@berkeley.edu, Vailoces, Valory Anne Sarmiento3 (AUTHOR) valory_vailoces@gwu.edu, Greene, Michelle K.1,4 (AUTHOR) cscott@avicedarx.com, Scott, Christopher J.1,4 (AUTHOR) dkunimoto@avicedarx.com, Kunimoto, Derek Y.1 (AUTHOR) thassan@avicedarx.com, Hassan, Tarek S.1,5 (AUTHOR) mgenead@avicedarx.com, Genead, Mohamed A.1 (AUTHOR), Tolentino, Michael J.1,6,7 (AUTHOR) vsendra@avicedarx.com
Zdroj: Pharmaceuticals (14248247). Apr2024, Vol. 17 Issue 4, p481. 21p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje